A randomized controlled trial assessed the efficacy of a novel gamified digital intervention in reducing ADHD symptoms and improving executive function in school-aged children, suggesting promising...
A cluster-randomized controlled trial examined the impact of personalized music on reducing agitation in nursing home residents with dementia, revealing significant reductions in verbally agitated behaviors...
A randomized controlled trial reveals that aquatic therapy significantly reduces pain intensity and improves sleep quality in women with fibromyalgia compared to traditional land-based therapy, highlighting...
Researchers aimed to describe the most common symptoms of long COVID and the progression of symptoms over time. They presented their findings at IDWeek 2023 in Boston, Massachusetts.
Rates of clinically diagnosed depression and anxiety without depression increased between 2017 and 2021, especially during the COVID-19 pandemic, according to recent cohort study results published in JAMA...
Researchers conducted a randomized trial to evaluate the impact of mindfulness-based stress reduction on depression and quality of life in older adults living with HIV and cognitive impairment.
In a long-term follow-up to SIERRA, a multicenter, randomized, controlled phase 3 study, researchers found that patients 55 years of age or older with active relapsed or refractory acute myeloid leukemia...
Although the immunotherapy plus chemotherapy did not improve disease-free survival (DFS) in newly diagnosed, high-risk patients with endometrial cancer, the combination therapy did improve DFS for patients...
Two randomized, double-blind studies demonstrated that a new antipsychotic treatment for adult patients with schizophrenia may lead to a meaningful reduction in symptoms.
